Chittorgarh sme ipo

Review By Dilip Davda on Jun 12, 2023 •VBML is engaged in the manufacturing and marketing of pharma products. •It is not selling its products under any brand names. •For the last three fiscals, it marked declining trends for top and bottom lines. •Super profits for 9M of FY23 raises eyebrows and concern over its sustainability. •The issue is greedily priced considering its financial performance. There is no harm in skipping it. ABOUT COMPANY: Vilin Bio Med Ltd. (VBML) is engaged in the domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand. It has also set up R & D facility at the said plant. Its product profile includes solid oral dosage form, oral liquids, external preparations and dry powders. Its Sales Strategy is to sell products in bulk to Pharmaceuticals Manufacturers, Marketers and Traders, who in turn provide the channel for sales to customers. VBML's products are primarily used by other pharmaceutical companies and traders, who ultimately market them to distributors and retail customers. The company does not sell products under any brand name. As of the date of filing this offer document, it had 61 employees on its payroll. ISSUE DETAILS/CAPITAL HISTORY: The company is coming out with a maiden IPO of 4000000 equity shares of Rs. 10 each at a fixed price of Rs. 30 per share to mobilize Rs. 12.00 cr. The issue opens for subscription on June 16, 2023, and will close on June 21, 2023. ...

An SME IPO, Krishca Strapping Solutions's offering of 3,320,000 equity shares with a face value of Rs. 10 aggregating up to ₹17.93 Crores. The issue price per share for the offering ranges from ₹51 to ₹54. The IPO opens on May 16, 2023 for subscription and will be closed on May 19, 2023. Purva Sharegistry India Pvt Ltd is the registrar for the IPO and the lead manager is Share India Capital Services Private Limited. Monday, May 29, 2023, is the anticipated date for the scheduled NSE SME listing of the shares of Krishca Strapping Solutions. According to the terms and conditions of the offer, qualified institutional buyers (QIBs) will receive 50% of the net offer, HNI/NII investors would receive 15% of the offer, and retail investors will receive the remaining 35%. According to the GMP trend, the grey market premium initially stood at roughly ₹28, but as of May 18th 2023, it jumped to as of May 18th 2023. According to the GMP chart, the expected listing price is being projected at roughly ₹129 per share while taking into account the upper end of the band pricing of Krishca Strapping Solutions Ltd's IPO at ₹54. As a result, it shows a strong listing premium of 138.89% for Krishca Strapping Solutions Ltd above the listing price estimated by the grey market. A R Ramachandran, Co-founder & Trainer-Tips2trades said “Even though profit turnaround has been great from FY22 onwards, high debt-equity ratio coupled with low ROE makes the Krishca Strapping Solutions IPO a slightly expen...

Symbol Series Adjusted 52 Week High High Date Adjusted 52 Week Low Low Date EQ ₹119.70 Aug 25, 2022 ₹60.35 Jun 20, 2022 EQ ₹30.85 Aug 29, 2022 ₹16.50 Mar 10, 2023 EQ ₹490.00 Jan 24, 2023 ₹308.95 Jun 20, 2022 3IINFOLTD EQ ₹54.20 Sep 12, 2022 ₹26.25 Mar 28, 2023 EQ ₹25,209.00 Oct 06, 2022 ₹17,273.00 May 27, 2022

SME IPO Dashboard presents a quick navigation through all the upcoming, current, and closed SME IPOs of the Indian Stock Market. Take a quick look at the SME IPO Open Date, Close Date, Listing Date, Issue Price, and Lot Size to take action as needed. Further, click on the company's name to get in-depth detailed review and all the information related to particular SME IPO. 0.23 Cr Shares TBD 0 26th Jun 2023 30th Jun 2023 5th Jul 2023 10th Jul 2023 Upcoming 0.37 Cr Shares TBD 0 Awaiting Awaiting Awaiting Awaiting Upcoming 0.62 Cr Shares 101-107 1200 23rd Jun 2023 27th Jun 2023 3rd Jul 2023 6th Jul 2023 Upcoming ₹12.00 Cr 30 4000 16th Jun 2023 21st Jun 2023 26th Jun 2023 30th Jun 2023 Open ₹38.40 Cr 60 2000 19th Jun 2023 21st Jun 2023 26th Jun 2023 30th Jun 2023 Upcoming Are you an SME company looking for an IPO to raise funds and get listed in the stock market? We can help. Contact us today... ₹50.34 Cr 100 1200 15th Jun 2023 20th Jun 2023 23rd Jun 2023 29th Jun 2023 Open 0.18 Cr Shares 298-314 400 14th Jun 2023 21st Jun 2023 26th Jun 2023 30th Jun 2023 Open ₹42.21 Cr 175 800 12th Jun 2023 15th Jun 2023 20th Jun 2023 23rd Jun 2023 Closed ₹11.42 Cr 100 1200 12th Jun 2023 14th Jun 2023 19th Jun 2023 22nd Jun 2023 Closed ₹105.14 Cr 169-173 800 9th Jun 2023 14th Jun 2023 19th Jun 2023 22nd Jun 2023 Closed ₹2.83 Cr 30 4000 7th Jun 2023 9th Jun 2023 14th Jun 2023 19th Jun 2023 Closed ₹18.00 Cr 180 800 2nd Jun 2023 7th Jun 2023 12th Jun 2023 14th Jun 2023 ₹12.30 Cr 52-54 2000 31st ...

Incorporated in 2014, Aatmaj Healthcare Limited runs multi-specialty hospitals, under the name Jupiter Hospitals, offering medical care at affordable rates. The company provides inpatient and outpatient healthcare services through its hospitals in Vadodara, Gujarat with an aggregate bed capacity of 130 beds extendable up to 175 beds. As on December 31, 2022, they have conducted an aggregate healthcare treatment, including surgeries, of over 17,000 patients, consisting of more than 4,000 patients and more than 13,000 OPD patients including Covid-19 Patients. The company's primary check-up services include hemoglobin check, lipid profile, general tests, renal profile, blood sugar, MCV, ESR, MCH, MCHC, liver profile, and lipid profile. Aatmaj Healthcare specializes in Nephrology and Uro surgery/Vascular surgery, Orthopedics, Joint replacement, Polytrauma care, Obstetric, Gynaecology, ENT, Ophthalmology, Plastic Surgery, and Neuro Surgery. The company is a part of Ayushman Bharat-Pradhan Mantri Jan ArogyaYojana, a flagship scheme of the Government of India which was launched and recommended by the National Health Policy 2017, to achieve the vision of universal health coverage (UHC). Aatmaj Healthcare IPO Details IPO Date Jun 19, 2023 to Jun 21, 2023 Listing Date [.] Face Value ₹5 per share Price ₹60 per share Lot Size 2000 Shares Total Issue Size 6,400,000 shares (aggregating up to ₹38.40 Cr) Fresh Issue 6,400,000 shares (aggregating up to ₹38.40 Cr) Issue Type Fixed Price Iss...

Incorporated in 2001, Cell Point (India) Limited is engaged in multi-brand retail selling of Smart Phones, tablets, mobile accessories, and mobile-related products and allied accessories from manufacturers like Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Redmi, and Oneplus. The company is also engaged in multi-brand retail selling of consumer durable electronics goods like Smart TVs of various brands such as Xiaomi, Realme, and One Plus. The company has over 75 stores across the state of Andhra Pradesh. Out of the 75 stores, 2 stores are owned properties and 73 stores are on leased properties. Cell Point (India) IPO Details IPO Date Jun 15, 2023 to Jun 20, 2023 Listing Date [.] Face Value ₹10 per share Price ₹100 per share Lot Size 1200 Shares Total Issue Size 5,034,000 shares (aggregating up to ₹50.34 Cr) Fresh Issue 5,034,000 shares (aggregating up to ₹50.34 Cr) Issue Type Fixed Price Issue IPO Listing At NSE SME Market Maker portion 252,000 shares Cell Point (India) IPO Timetable (Tentative) Cell Point (India) IPO opens on Jun 15, 2023, and closes on Jun 20, 2023. Event Tentative Date Opening Date Thursday, 15 June 2023 Closing Date Tuesday, 20 June 2023 Basis of Allotment Friday, 23 June 2023 Initiation of Refunds Monday, 26 June 2023 Credit of Shares to Demat Tuesday, 27 June 2023 Listing Date Thursday, 29 June 2023 Cut-off time for UPI mandate confirmation 5 PM on Jun 20, 2023 Cell Point (India) Limited Financial Information (Restated) Period Ended Total Asset...

1 Company DRHP Filing Date Draft Red Herring Prospectus / Draft Prospectus Red Herring Prospectus Prospectus Basis of allotment advertisement 16/06/2023 15/06/2023 14/06/2023 12/06/2023 10/06/2023 09/06/2023 09/06/2023 03/06/2023 02/06/2023 02/06/2023 23/05/2023 19/05/2023 18/05/2023 16/05/2023 16/05/2023 10/05/2023 10/05/2023 02/05/2023 29/04/2023 28/04/2023 24/04/2023 21/04/2023 20/04/2023 17/04/2023 13/04/2023 1

Review By Dilip Davda on Jun 12, 2023 •VBML is engaged in the manufacturing and marketing of pharma products. •It is not selling its products under any brand names. •For the last three fiscals, it marked declining trends for top and bottom lines. •Super profits for 9M of FY23 raises eyebrows and concern over its sustainability. •The issue is greedily priced considering its financial performance. There is no harm in skipping it. ABOUT COMPANY: Vilin Bio Med Ltd. (VBML) is engaged in the domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand. It has also set up R & D facility at the said plant. Its product profile includes solid oral dosage form, oral liquids, external preparations and dry powders. Its Sales Strategy is to sell products in bulk to Pharmaceuticals Manufacturers, Marketers and Traders, who in turn provide the channel for sales to customers. VBML's products are primarily used by other pharmaceutical companies and traders, who ultimately market them to distributors and retail customers. The company does not sell products under any brand name. As of the date of filing this offer document, it had 61 employees on its payroll. ISSUE DETAILS/CAPITAL HISTORY: The company is coming out with a maiden IPO of 4000000 equity shares of Rs. 10 each at a fixed price of Rs. 30 per share to mobilize Rs. 12.00 cr. The issue opens for subscription on June 16, 2023, and will close on June 21, 2023. ...

1 Company DRHP Filing Date Draft Red Herring Prospectus / Draft Prospectus Red Herring Prospectus Prospectus Basis of allotment advertisement 16/06/2023 15/06/2023 14/06/2023 12/06/2023 10/06/2023 09/06/2023 09/06/2023 03/06/2023 02/06/2023 02/06/2023 23/05/2023 19/05/2023 18/05/2023 16/05/2023 16/05/2023 10/05/2023 10/05/2023 02/05/2023 29/04/2023 28/04/2023 24/04/2023 21/04/2023 20/04/2023 17/04/2023 13/04/2023 1

Incorporated in 2014, Aatmaj Healthcare Limited runs multi-specialty hospitals, under the name Jupiter Hospitals, offering medical care at affordable rates. The company provides inpatient and outpatient healthcare services through its hospitals in Vadodara, Gujarat with an aggregate bed capacity of 130 beds extendable up to 175 beds. As on December 31, 2022, they have conducted an aggregate healthcare treatment, including surgeries, of over 17,000 patients, consisting of more than 4,000 patients and more than 13,000 OPD patients including Covid-19 Patients. The company's primary check-up services include hemoglobin check, lipid profile, general tests, renal profile, blood sugar, MCV, ESR, MCH, MCHC, liver profile, and lipid profile. Aatmaj Healthcare specializes in Nephrology and Uro surgery/Vascular surgery, Orthopedics, Joint replacement, Polytrauma care, Obstetric, Gynaecology, ENT, Ophthalmology, Plastic Surgery, and Neuro Surgery. The company is a part of Ayushman Bharat-Pradhan Mantri Jan ArogyaYojana, a flagship scheme of the Government of India which was launched and recommended by the National Health Policy 2017, to achieve the vision of universal health coverage (UHC). Aatmaj Healthcare IPO Details IPO Date Jun 19, 2023 to Jun 21, 2023 Listing Date [.] Face Value ₹5 per share Price ₹60 per share Lot Size 2000 Shares Total Issue Size 6,400,000 shares (aggregating up to ₹38.40 Cr) Fresh Issue 6,400,000 shares (aggregating up to ₹38.40 Cr) Issue Type Fixed Price Iss...